Single dose intravenous injection of BBM 002
IIT2022019
Phase 1 gene_therapy active
Quick answer
Single dose intravenous injection of BBM 002 for Hemophilia A is a Phase 1 program (gene_therapy) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Hemophilia A
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- active